Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) News

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Today's Latest Price: $9.35 USD

0.09 (-0.95%)

Updated Oct 23 7:00pm

Add TEVA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter TEVA News Items

TEVA News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest TEVA News From Around the Web

Below are the latest news stories about Teva Pharmaceutical Industries Ltd that investors may wish to consider to help them evaluate TEVA as an investment opportunity.

US appeals court revives Glaxo US$235.5 million verdict against Teva

A federal appeals court on Friday reinstated a 2017 jury verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than US$235 million for infringing a patent for its blood pressure drug Coreg.

Channel NewsAsia | October 2, 2020

Topical Antibiotic Pharmaceuticals Market Poised for Strong Growth Worldwide by 2020-2025 | Spotlight on Top Vendors Like Teva, Perrigo, Taro, Pfizer, Glenmark, GSK, Fera and Watson

The growing demand for Topical Antibiotic Pharmaceuticals has provided a major boost to the Global Topical Antibiotic Pharmaceuticals Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high

OpenPR | October 1, 2020

Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter financial results, Thursday November 5, 2020 at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States 1-866-966-1396; Israel 1-809-203-6

Business Wire | October 1, 2020

Vaginitis Therapeutics Market Shares and SWOT Analysis by Lupin, Pfizer Inc, Sanofi, Teva Pharmaceutical Industries Ltd, Bausch Health, DARÉ BIOSCIENCE, INC

Vaginitis Therapeutics Market By Types (Bacterial Vaginosis, Trichomoniasis, Vulvovaginal Candidiasis and Others), Drug Class (Anti-fungal, Anti-bacterial, Hormone and Others), Medication Type (Over-The-Counter (OTC), Prescription (Rx)), Route of Administration (Oral, Topical), End- Users (Hospitals, Specialized Gynecology Centers and Others), Distribution Channel

OpenPR | September 30, 2020

Biosimilars Market Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts 2026(Sandoz International GmbH, Teva Pharmaceuticals Industries, Amgen Inc)

Los Angeles, United State, – – QY Research recently added a research report, Global Biosimilars Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Biosimilars market. It highlights the drivers and restraints

OpenPR | September 30, 2020

Decongestant Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026(Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals Ltd.)

Los Angeles, United State, – – QY Research recently added a research report, Global Decongestant Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Decongestant market. It highlights the drivers and restraints

OpenPR | September 30, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $TEVA #CLASSACTION--Glancy Prongay & Murray, Securities Fraud Law Firm, Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of Investors

Business Wire | September 30, 2020

Estrogen Market Recent Trends and Developments, Challenges and Opportunities, key drivers and Restraints over the Forecast Period 2020-2026(Teva Pharmaceuticals, Bayer, Xi'an Sgonek Biological Technology)

Los Angeles, United State, – – QY Research recently added a research report, Global Estrogen Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Estrogen market. It highlights the drivers and restraints

OpenPR | September 30, 2020

Vitamin A Palmitate Market trending worldwide, growth over Forecast Period 2020-2028| Prominent Players Hospira, Banner Pharmacaps, AstraZeneca, Teva Pharmaceutical Industries, Impax Laboratories

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Vitamin A Palmitate Market which would mention How the Covid-19 is affecting the Vitamin A Palmitate Industry, Market

OpenPR | September 28, 2020

Rituximab Biosimilars Market Is Booming Worldwide (2020-2023) | By Top Leading Players – Pfizer Inc., Mylan Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd.

The Business Research Company offers "Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it

OpenPR | September 28, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7712 seconds.